Syntara Limited (SNT) Earnings Call Transcript & Summary

We have a quorum, and I now declare the meeting open. My name is David McGarvey, the Company Secretary of Syntara. I've recently retired from my role as CFO, but I'm continuing as the Company Secretary on a part-time basis. Today's meeting is being held as a virtual meeting via live webcast with the use of the Zoom platform and also the Lumi meeting platform for voting. Shareholders and proxies have the ability to ask questions via Zoom and submit votes via the Lumi platform. You need to be logged into both platforms if you wish to participate and vote. Firstly, let me introduce our Board, Dr. Kathleen Metters, Executive -- Non-Executive Chair.

Good morning.

Mr. Gary Phillips, our Chief Executive.

Good morning.

Dr. Simon Green, Non-Executive Director.

Welcome, everybody.

Mr. Hashan De Silva, Non-Executive Director.

Good morning.

I would also like to take this opportunity to introduce our new CFO, Mr. Tim Luscombe.

Good morning.

We will take the Notice of the Meeting and the Proposed Resolution as read, but we will also display them as the meeting progresses. Questions can be submitted online at any time. For shareholders and proxies wishing to submit a written question, select the Q&A button in the center of the bottom tool bar, then type out your question in the text box provided and submit. Please note that while you can submit questions from now on, we will address them at the relevant time in the meeting, which will be after proposing each item of business. If shareholders and proxies would like to submit your question verbally, click the raise hand button in the center of the bottom toolbar at the appropriate time when we ask for questions. When the presenter then prompts you, for your question, you will be provided with microphone access and the system will ask you to confirm your microphone settings. And once confirmed, you will be able to speak. Please introduce yourself and advise whether you are a shareholder or a proxy holder. Voting today will be conducted by way of a poll on all items of business using the separate Lumi meeting platform. In order to provide you with enough time to vote. Voting is now open for all resolutions. If you are eligible to vote at this meeting, a polling icon has or will shortly appear on the Lumi meeting platform. Selecting this icon will bring up a list of resolutions and present you with voting options. To cast your vote, simply select one of the options. You have the ability to change your vote up until the time we declare voting closed, which will be towards the end of the meeting. I would now like to hand over to the Chair of the company and of this meeting Dr. Kathleen Metters.

The purpose of today's meeting is to ratify and approve the issuance of shares as part of our recently announced 2-Tranche placement. The company is also seeking approval for the fund KP Rx to acquire shares in Tranche 2 of the placement, KP Rx is associated with one of our directors, Mr. Hashan De Silva. At the outset, I would like to thank KP Rx and the other investors that have participated in the capital raising. So thank you for participating. We will proceed with the formal items of business. Resolution 1. Resolution 1 is an ordinary resolution that seeks approval for the KP Rx Healthcare Trust or its nominee an associate of our Director, Mr. Hashan De Silva to participate in the second tranche of the placement. Voting exclusions apply with respect to Resolution 1. The proxy votes received prior to the meeting are set out online. Does anyone have any questions in relation to Resolution 1. Are there any questions?

There are no questions, Kathleen.

Then in that case, resolution to Resolution 2 is an ordinary resolution that relates to the ratification of the issue of shares under the first tranche placement we announced in July 2024. In order to refresh the company's 15% capacity. Voting exclusions apply in respect to Resolution 2. The proxy votes received prior to the meeting are set out online. Are there any questions in relation to Resolution 2?

There are no questions, Kathleen.

Resolution 3 is an ordinary resolution that relates to the approval of the agreement to issue under the second tranche of the placement we announced in July 2024. Voting exclusions apply with respect to Resolution 3. The proxy votes received prior to the meeting are set out online. Does anyone have any questions in relation to Resolution 3?

There are no questions, Kathleen.

That concludes our discussion on the items of business. I'm about to close the voting system. Please ensure that you have cast your votes on all resolutions. I will pose briefly to allow you time to finalize those votes. Voting is now closed. The results of these votes will be released to the stock exchange later today. As there is no further business, I declare the meeting closed, and thank you for attending.